Professor Zemin Zhang, President of Chongqing Medical University and former Director of the Biomedical Pioneering Innovation Center (BIOPIC) at Peking University, is internationally recognized for his pioneering work in cancer genomics, bioinformatics, and tumor immunology. He earned his B.S. in Genetics from Nankai University and a Ph.D. in Biochemistry and Molecular Biology from Pennsylvania State University, followed by postdoctoral training at the University of California, San Francisco (UCSF). Before returning to China in 2014, he spent over 16 years at Genentech/Roche, where he led the cancer genomics and bioinformatics group, making significant contributions to the discovery of anticancer targets and biomarkers. Since joining Peking University, Professor Zhang has applied advanced genomics and bioinformatics approaches to systematically elucidate the tumor microenvironment, revealing the heterogeneity of immune cells and the mechanisms underlying therapeutic responses. His laboratory also develops original bioinformatics tools that facilitate data analysis, integration, and visualization. Professor Zhang has published extensively in Cell, Nature, Science, and Cancer Cell, with his work cited over 60,000 times. He serves on the editorial boards of Cell, Cancer Cell, and Cancer Discovery. He is a Cheung Kong Distinguished Professor and an elected Member of the Chinese Academy of Sciences, recognizing his contributions to biomedical research and higher education.